BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35310607)

  • 1. Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer.
    Li T; Liu W; Wang C; Wang M; Hui W; Lu J; Gao F
    J Immunol Res; 2022; 2022():5164265. PubMed ID: 35310607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of LY6E is an independent prognostic factor of colorectal cancer patients.
    Kim HJ; Hong I; Roh S; Kim S; Kim H; Oh S; Ahn TS; Kang DH; Baek MJ; Jeong D
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36866762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
    Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
    BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer.
    Zhang L; Cao L; Liu J; Duan L; Zhou W; Li T; Guan L; Wu X; Zhang H
    Aging (Albany NY); 2023 Jun; 15(11):5164-5189. PubMed ID: 37310469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    J Cell Mol Med; 2019 Aug; 23(8):5200-5210. PubMed ID: 31144439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
    Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
    Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
    Yang ZD; Kang H
    World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
    Liu S; Cao Q; An G; Yan B; Lei L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic and Molecular Landscape of Autophagy-Related Long Noncoding RNA in Colorectal Cancer.
    Sun Y; Cao X; Guo Y; Liu B; Zhang Y
    Biomed Res Int; 2022; 2022():5614915. PubMed ID: 35097120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T-cell costimulator as a crucial immune checkpoint molecule.
    Chu J; Wu Y; Qu Z; Zhuang J; Liu J; Han S; Wu W; Han S
    Cancer Med; 2024 Mar; 13(6):e7097. PubMed ID: 38506253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
    Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
    Front Immunol; 2022; 13():951135. PubMed ID: 36483555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.
    Chen Y; Zhou H; Wang Z; Huang Z; Wang J; Zheng M; Ni X; Liu L
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33960364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
    Wang W; Bo H; Liang Y; Li G
    Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
    Zhou L; Ye J; Wen F; Yu H
    Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.